Interactions between nanosized materials and the brain

Current Medicinal Chemistry

Volumn 21, Issue 37, 2014, Pages 4200-4214

  Simko M ^a   Mattsson, Mats Olof ^a  

^a AIT AUSTRIAN INSTITUTE OF TECHNOLOGY   (Austria)

Author keywords

Axonal transport; Blood brain barrier; Brain; In vitro; In vivo; Nanoparticle; Translocation; Unintended and intended exposure

Indexed keywords

COSMETIC; NANOPARTICLE; SILVER NANOPARTICLE; TITANIUM DIOXIDE; NANOMATERIAL;

ARTICLE; BLOOD BRAIN BARRIER; CHEMICAL INTERACTION; DRUG DELIVERY SYSTEM; HOMEOSTASIS; NANOTECHNOLOGY; NERVE FIBER TRANSPORT; NERVOUS SYSTEM; NEUROTOXICITY; NEUROTRANSMISSION; OCCUPATIONAL EXPOSURE; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PARTICLE SIZE; RESPIRATORY SYSTEM; ULTRAVIOLET RADIATION; CENTRAL NERVOUS SYSTEM DISEASES; CHEMISTRY; DRUG EFFECTS; HUMAN; METABOLISM;

BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; NANOSTRUCTURES; NANOTECHNOLOGY; PARTICLE SIZE;

EID: 84928670703     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867321666140716100449     Document Type: Article

References (92)

1. Oberdorster, G.; Oberdorster, E.; Oberdorster, J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect., 2005, 113(7), 823-839.
2. Taylor, U.; Barchanski, A.; Kues, W.; Barcikowski, S.; Rath, D. Impact of metal nanoparticles on germ cell viability and functionality. Reprod. Domest. Anim., 2012, 47 Suppl 4, 359-368.
3. Johnston, H. J.; Hutchison, G.; Christensen, F. M.; Peters, S.; Hankin, S.; Stone, V. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit. Rev. Toxicol., 2010, 40(4), 328-346.
4. Hanley, C.; Layne, J.; Punnoose, A.; Reddy, K. M.; Coombs, I.; Coombs, A.; Feris, K.; Wingett, D. Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles. Nanotechnology, 2008, 19(29), 295103.
5. Premanathan, M.; Karthikeyan, K.; Jeyasubramanian, K.; Manivannan, G. Selective toxicity of ZnO nanoparticles toward Grampositive bacteria and cancer cells by apoptosis through lipid peroxidation. Nanomedicine, 2011, 7(2), 184-192.
6. Ventola, C. L. The nanomedicine revolution: part 2: current and future clinical applications. P & T, 2012, 37(10), 582-591.
7. Johnston, H.; Pojana, G.; Zuin, S.; Jacobsen, N. R.; Moller, P.; Loft, S.; Semmler-Behnke, M.; McGuiness, C.; Balharry, D.; Marcomini, A.; Wallin, H.; Kreyling, W.; Donaldson, K.; Tran, L.; Stone, V. Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: potential solutions to current and future challenges. Crit. Rev. Toxicol., 2013, 43(1), 1-20.
8. Kendall, M.; Holgate, S. Health impact and toxicological effects of nanomaterials in the lung. Respirology (Carlton, Vic.), 2012, 17(5), 743-758.
9. Simkó, M.; Mattsson, M. O. Risks from accidental exposures to engineered nanoparticles and neurological health effects: a critical review. Part. Fibre Toxicol., 2010, 7, 42.
10. Kuhlbusch, T. A.; John, A. C.; Quass, U. Sources and source contributions to fine particles. Biomarkers, 2009, 14 Suppl 1, 23-28.
11. Peters, T. M.; Elzey, S.; Johnson, R.; Park, H.; Grassian, V. H.; Maher, T.; O'Shaughnessy, P. Airborne monitoring to distinguish engineered nanomaterials from incidental particles for environmental health and safety. J. Occcup. Environ. Hygiene, 2009, 6(2), 73-81.
12. HSE Review of the adequacy of current regulatory regimes to secure effective regulation of nanoparticles created by nanotechnology; HSE: 2006; p 22.
13. Möhlmann, C. In Exposition gegenüber ultrafeinen Partikeln an Arbeitsplätzen (Konferenzbeitrag), Dialog zur Bewertung von synthetischen Nanopartikeln in Arbeits- und Umweltbereichen, Bonn, 11. Oktober 2005, 2005; Bonn, 2005.
14. Möhlmann, C. BIA-Workshop "Ultrafine aerosols at workplaces".; Hauptverband der Gewerblichen Berufsgenossenschaften (HVBG):21 and 22 august 2003, 2003.
15. Aitken, R. J.; Chaudhry, M. Q.; Boxall, A. B.; Hull, M., Manufacture and use of nanomaterials: current status in the UK and global trends. Occup. Med., 2006, 2006(56), 300-306.
16. Maynard, A. D. New carbon nanotube study raises the health impact stakes. http://community.safenano.org/blogs/andrew-maynard/archive/2009/03/26/new-carbon-nanotube-study-raises-the-healthimpact-stakes.aspx (04.06.2009)
17. Maynard, A. D.; Aitken, R. J. Assessing exposure to airborne nanomaterials: Current abilities and future requirements. Nanotoxicology, 2007, 1(1), 26-41.
18. Methner, M. M.; Birch, M. E.; Evans, D. E.; Ku, B. K.; Crouch, K.; Hoover, M. D. Identification and characterization of potential sources of worker exposure to carbon nanofibers during polymer composite laboratory operations. J. Occup. Environ. Hyg., 2007, 4(12), D125-D130.
19. Schneider, T. Role of occupational hygiene research in the control of occupational health risks from engineered nanoparticles. Scand. J. Work. Environ. Health., 2008, 34(6), 407-409.
20. Donaldson, K.; Tran, L.; Jimenez, L. A.; Duffin, R.; Newby, D. E.; Mills, N.; MacNee, W.; Stone, V. Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure. Part. Fibre Toxicol., 2005, 2, 10.
21. Beru Be, K.; Balharry, D.; Sexton, K.; Koshy, L.; Jones, T. Combustion-derived nanoparticles: mechanisms of pulmonary toxicity. Clin. Exp. Pharmacol. Physiol., 2007, 34(10), 1044-1050.
22. Ramachandran, G.; Ostraat, M.; Evans, D. E.; Methner, M. M.; O'Shaughnessy, P.; D'Arcy, J.; Geraci, C. L.; Stevenson, E.; Maynard, A.; Rickabaugh, K. A strategy for assessing workplace exposures to nanomaterials. J. Occup. Environ. Hyg., 2011, 8(11), 673-685.
23. Plitzko, S. Workplace exposure to engineered nanoparticles. Inhal. Toxicol., 2009, 21 Suppl. 1, 25-29.
24. Brouwer, D. Exposure to manufactured nanoparticles in different workplaces. Toxicology, 2010, 269(2-3), 120-127.
25. Wang, Y. F.; Tsai, P. J.; Chen, C. W.; Chen, D. R.; Hsu, D. J. Using a modified electrical aerosol detector to predict nanoparticle exposures to different regions of the respiratory tract for workers in a carbon black manufacturing industry. Environ. Sci. Technol., 2010, 44(17), 6767-6774.
26. Lee, J. H.; Lee, S. B.; Bae, G. N.; Jeon, K. S.; Yoon, J. U.; Ji, J. H.; Sung, J. H.; Lee, B. G.; Lee, J. H.; Yang, J. S.; Kim, H. Y.; Kang, C. S.; Yu, I. J. Exposure assessment of carbon nanotube manufacturing workplaces. Inhal. Toxicol., 2010, 22(5), 369-381.
27. Lee, J. H.; Sohn, E. K.; Ahn, J. S.; Ahn, K.; Kim, K. S.; Lee, J. H.; Lee, T. M.; Yu, I. J., Exposure assessment of workers in printed electronics workplace. Inhal. Toxicol., 2013, 25(8), 426-434.
28. Phalen, R. F.; Hoover, M. D. Aerosol dosimetry research needs. Inhal. Toxicol., 2006, 18(10), 841-843.
29. Robichaud, C. O.; Uyar, A. E.; Darby, M. R.; Zucker, L. G.; Wiesner, M. R. Estimates of upper bounds and trends in nano-TiO2 production as a basis for exposure assessment. Environ. Sci. Technol., 2009, 43(12), 4227-4233.
30. Shi, H.; Magaye, R.; Castranova, V.; Zhao, J. Titanium dioxide nanoparticles: a review of current toxicological data. Part. Fibre Toxicol., 2013, 10, 15.
31. Devadasu, V. R.; Bhardwaj, V.; Kumar, M. N. Can controversial nanotechnology promise drug delivery? Chem. Rev., 2013, 113(3), 1686-1735.
32. Singh, S.; Sharma, A.; Robertson, G. P. Realizing the clinical potential of cancer nanotechnology by minimizing toxicologic and targeted delivery concerns. Cancer Res., 2012, 72(22), 5663-5668.
33. Murashov, V. Occupational exposure to nanomedical applications. Nanomed. Nanobiotechnol., 2009, 1(2), 203-213.
34. Schreiber, C.; Radon, K.; Pethran, A.; Schierl, R.; Hauff, K.; Grimm, C. H.; Boos, K. S.; Nowak, D. Uptake of antineoplastic agents in pharmacy personnel. Part II: study of work-related risk factors. Int. Arch. Occup. Environ. Health, 2003, 76(1), 11-16.
35. Bradbury, M. W. The blood-brain barrier. Exp. Physiol., 1993, 78(4), 453-472.
36. Yang, Z.; Liu, Z. W.; Allaker, R. P.; Reip, P.; Oxford, J.; Ahmad, Z.; Ren, G. A review of nanoparticle functionality and toxicity on the central nervous system. Journal of the Royal Society, Interface/the Royal Society, 2010, 7 Suppl 4, S411-S422.
37. Ye, D.; Raghnaill, M. N.; Bramini, M.; Mahon, E.; Aberg, C.; Salvati, A.; Dawson, K. A. Nanoparticle accumulation and transcytosis in brain endothelial cell layers. Nanoscale, 2013, 5(22), 11153-11165.
38. Raghnaill, M. N.; Bramini, M.; Ye, D.; Couraud, P. O.; Romero, I. A.; Weksler, B.; Aberg, C.; Salvati, A.; Lynch, I.; Dawson, K. A. Paracrine signalling of inflammatory cytokines from an in vitro blood brain barrier model upon exposure to polymeric nanoparticles. Analyst, 2014, 139(5), 923-930.
39. Trickler, W. J.; Lantz, S. M.; Murdock, R. C.; Schrand, A. M.; Robinson, B. L.; Newport, G. D.; Schlager, J. J.; Oldenburg, S. J.; Paule, M. G.; Slikker, W., Jr.; Hussain, S. M.; Ali, S. F. Silver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells. Toxicol. Sci., 2010, 118(1), 160-170.
40. Trickler, W. J.; Lantz, S. M.; Murdock, R. C.; Schrand, A. M.; Robinson, B. L.; Newport, G. D.; Schlager, J. J.; Oldenburg, S. J.; Paule, M. G.; Slikker, W., Jr.; Hussain, S. M.; Ali, S. F. Brain microvessel endothelial cells responses to gold nanoparticles: In vitro pro-inflammatory mediators and permeability. Nanotoxicology, 2011, 5(4), 479-492.
41. Brun, E.; Carriere, M.; Mabondzo, A. In vitro evidence of dysregulation of blood-brain barrier function after acute and repeated/longterm exposure to TiO (2) nanoparticles. Biomaterials, 2012, 33(3), 886-896.
42. Bondy, S. C. Nanoparticles and colloids as contributing factors in neurodegenerative disease. Int. J. Environ. Res. Public Health, 2011, 8(6), 2200-2211.
43. Yokel, R.; Grulke, E.; MacPhail, R. Metal-based nanoparticle interactions with the nervous system: the challenge of brain entry and the risk of retention in the organism. Wiley interdisciplinary reviews. Nanomed. Nanobiotechnol., 2013, 5(4), 346-373.
44. Ma, L.; Liu, J.; Li, N.; Wang, J.; Duan, Y.; Yan, J.; Liu, H.; Wang, H.; Hong, F. Oxidative stress in the brain of mice caused by translocated nanoparticulate TiO2 delivered to the abdominal cavity. Biomaterials, 2010, 31(1), 99-105.
45. Lee, J. H.; Kim, Y. S.; Song, K. S.; Ryu, H. R.; Sung, J. H.; Park, J. D.; Park, H. M.; Song, N. W.; Shin, B. S.; Marshak, D.; Ahn, K.; Lee, J. E.; Yu, I. J. Biopersistence of silver nanoparticles in tissues from Sprague-Dawley rats. Part. Fibre Toxicol., 2013, 10, 36.
46. Van Der Zande, M.; Vandebriel, R. J.; Van Doren, E.; Kramer, E.; Herrera Rivera, Z.; Serrano-Rojero, C. S.; Gremmer, E. R.; Mast, J.; Peters, R. J.; Hollman, P. C.; Hendriksen, P. J.; Marvin, H. J.; Peijnenburg, A. A.; Bouwmeester, H. Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano, 2012, 6(8), 7427-7442.
47. Lankveld, D. P.; Oomen, A. G.; Krystek, P.; Neigh, A.; Troost-De Jong, A.; Noorlander, C. W.; Van Eijkeren, J. C.; Geertsma, R. E.; De Jong, W. H. The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials, 2010, 31(32), 8350-8361.
48. Singh, S. P.; Rahman, M. F.; Murty, U. S.; Mahboob, M.; Grover, P. Comparative study of genotoxicity and tissue distribution of nano and micron sized iron oxide in rats after acute oral treatment. Toxicol. Appl. Pharmacol., 2013, 266(1), 56-66.
49. Petitot, F.; Lestaevel, P.; Tourlonias, E.; Mazzucco, C.; Jacquinot, S.; Dhieux, B.; Delissen, O.; Tournier, B. B.; Gensdarmes, F.; Beaunier, P.; Dublineau, I., Inhalation of uranium nanoparticles: respiratory tract deposition and translocation to secondary target organs in rats. Toxicol. Lett., 2013, 217(3), 217-225.
50. Naik, P.; Cucullo, L. In vitro blood-brain barrier models: current and perspective technologies. J. Pharm. Sci., 2012, 101(4), 1337-1354.
51. Hoff, D.; Sheikh, L.; Bhattacharya, S.; Nayar, S.; Webster, T. J. Comparison study of ferrofluid and powder iron oxide nanoparticle permeability across the blood-brain barrier. Int. J. Nanomed., 2013, 8, 703-710.
52. Tang, J.; Xiong, L.; Zhou, G.; Wang, S.; Wang, J.; Liu, L.; Li, J.; Yuan, F.; Lu, S.; Wan, Z.; Chou, L.; Xi, T. Silver nanoparticles crossing through and distribution in the blood-brain barrier in vitro. J. Nanosci. Nanotechnol., 2010, 10(10), 6313-6317.
53. Lucchini, R. G.; Dorman, D. C.; Elder, A.; Veronesi, B. Neurological impacts from inhalation of pollutants and the nose-brain connection. Neurotoxicology, 2012, 33(4), 838-841.
54. Wu, J.; Ding, T.; Sun, J. Neurotoxic potential of iron oxide nanoparticles in the rat brain striatum and hippocampus. Neurotoxicology, 2013, 34, 243-253.
55. Zhang, L.; Bai, R.; Li, B.; Ge, C.; Du, J.; Liu, Y.; Le Guyader, L.; Zhao, Y.; Wu, Y.; He, S.; Ma, Y.; Chen, C. Rutile TiO (2) particles exert size and surface coating dependent retention and lesions on the murine brain. Toxicol. Lett., 2011, 207(1), 73-81.
56. Zhang, L.; Bai, R.; Liu, Y.; Meng, L.; Li, B.; Wang, L.; Xu, L.; Le Guyader, L.; Chen, C. The dose-dependent toxicological effects and potential perturbation on the neurotransmitter secretion in brain following intranasal instillation of copper nanoparticles. Nanotoxicology, 2012, 6(5), 562-575.
57. Hopkins, L. E.; Patchin, E. S.; Chiu, P. L.; Brandenberger, C.; Smiley-Jewell, S.; Pinkerton, K. E. Nose-to-brain transport of aerosolised quantum dots following acute exposure. Nanotoxicology, 2014, 8, 885-893.
58. Scuri, M.; Chen, B. T.; Castranova, V.; Reynolds, J. S.; Johnson, V. J.; Samsell, L.; Walton, C.; Piedimonte, G. Effects of titanium dioxide nanoparticle exposure on neuroimmune responses in rat airways. J. Toxicol. Environ. Health A., 2010, 73(20), 1353-1369.
59. Cui, Y.; Chen, X.; Zhou, Z.; Lei, Y.; Ma, M.; Cao, R.; Sun, T.; Xu, J.; Huo, M.; Cao, R.; Wen, C.; Che, Y. Prenatal exposure to nanoparticulate titanium dioxide enhances depressive-like behaviors in adult rats. Chemosphere, 2014, 96, 99-104.
60. Xu, J.; Shi, H.; Ruth, M.; Yu, H.; Lazar, L.; Zou, B.; Yang, C.; Wu, A.; Zhao, J. Acute toxicity of intravenously administered titanium dioxide nanoparticles in mice. PloS One, 2013, 8(8), e70618.
61. Umezawa, M.; Tainaka, H.; Kawashima, N.; Shimizu, M.; Takeda, K. Effect of fetal exposure to titanium dioxide nanoparticle on brain development - brain region information. J. Toxicol. Sci., 2012, 37(6), 1247-1252.
62. Ze, Y.; Zheng, L.; Zhao, X.; Gui, S.; Sang, X.; Su, J.; Guan, N.; Zhu, L.; Sheng, L.; Hu, R.; Cheng, J.; Cheng, Z.; Sun, Q.; Wang, L.; Hong, F. Molecular mechanism of titanium dioxide nanoparticles-induced oxidative injury in the brain of mice. Chemosphere, 2013, 92(9), 1183-1189.
63. Ahamed, M.; Al Salhi, M. S.; Siddiqui, M. K. J. Silver nanoparticle applications and human health. Clinica Chimica Acta, 2010, 411(23-24), 1841-1848.
64. Hadrup, N.; Loeschner, K.; Mortensen, A.; Sharma, A. K.; Qvortrup, K.; Larsen, E. H.; Lam, H. R. The similar neurotoxic effects of nanoparticulate and ionic silver in vivo and in vitro. Neurotoxicology, 2012, 33(3), 416-423.
65. Liu, P.; Huang, Z.; Gu, N. Exposure to silver nanoparticles does not affect cognitive outcome or hippocampal neurogenesis in adult mice. Ecotoxicol. Environ. Saf., 2013, 87, 124-130.
66. Tranquada, J. M.; Woo, H.; Perring, T. G.; Goka, H.; Gu, G. D.; Xu, G.; Fujita, M.; Yamada, K. Quantum magnetic excitations from stripes in copper oxide superconductors. Nature, 2004, 429(6991), 534-538.
67. An, L.; Liu, S.; Yang, Z.; Zhang, T. Cognitive impairment in rats induced by nano-CuO and its possible mechanisms. Toxicol. Lett., 2012, 213(2), 220-227.
68. Chen, L.; Miao, Y.; Chen, L.; Jin, P.; Zha, Y.; Chai, Y.; Zheng, F.; Zhang, Y.; Zhou, W.; Zhang, J.; Wen, L.; Wang, M. The role of elevated autophagy on the synaptic plasticity impairment caused by CdSe/ZnS quantum dots. Biomaterials, 2013, 34(38), 10172-10181.
69. Trpkovic, A.; Todorovic-Markovic, B.; Trajkovic, V. Toxicity of pristine versus functionalized fullerenes: mechanisms of cell damage and the role of oxidative stress. Arch. Toxicol., 2012, 86(12), 1809-1827.
70. Wu, J.; Sun, J.; Xue, Y. Involvement of JNK and P53 activation in G2/M cell cycle arrest and apoptosis induced by titanium dioxide nanoparticles in neuron cells. Toxicol. Lett., 2010, 199(3), 269-276.
71. Guo, D.; Bi, H.; Liu, B.; Wu, Q.; Wang, D.; Cui, Y. Reactive oxygen species-induced cytotoxic effects of zinc oxide nanoparticles in rat retinal ganglion cells. Toxicol. in Vitro, 2013, 27(2), 731-738.
72. Valdiglesias, V.; Costa, C.; Kilic, G.; Costa, S.; Pasaro, E.; Laffon, B.; Teixeira, J. P. Neuronal cytotoxicity and genotoxicity induced by zinc oxide nanoparticles. Environ. Int., 2013, 55, 92-100.
73. Haase, A.; Rott, S.; Mantion, A.; Graf, P.; Plendl, J.; Thunemann, A. F.; Meier, W. P.; Taubert, A.; Luch, A.; Reiser, G. Effects of silver nanoparticles on primary mixed neural cell cultures: uptake, oxidative stress and acute calcium responses. Toxicol. Sci., 2012, 126(2), 457-468.
74. Xu, F.; Piett, C.; Farkas, S.; Qazzaz, M.; Syed, N. I. Silver nanoparticles (AgNPs) cause degeneration of cytoskeleton and disrupt synaptic machinery of cultured cortical neurons. Mol. Brain, 2013, 6(1), 29.
75. Hohnholt, M. C.; Geppert, M.; Luther, E. M.; Petters, C.; Bulcke, F.; Dringen, R. Handling of iron oxide and silver nanoparticles by astrocytes. Neurochem. Res., 2013, 38(2), 227-239.
76. Pinkernelle, J.; Calatayud, P.; Goya, G. F.; Fansa, H.; Keilhoff, G. Magnetic nanoparticles in primary neural cell cultures are mainly taken up by microglia. BMC Neurosci., 2012, 13, 32.
77. Kim, J. A.; Lee, N.; Kim, B. H.; Rhee, W. J.; Yoon, S.; Hyeon, T.; Park, T. H. Enhancement of neurite outgrowth in PC12 cells by iron oxide nanoparticles. Biomaterials, 2011, 32(11), 2871-2877.
78. Wang, F.; Jiao, C.; Liu, J.; Yuan, H.; Lan, M.; Gao, F. Oxidative mechanisms contribute to nanosize silican dioxide-induced developmental neurotoxicity in PC12 cells. Toxicol. in Vitro, 2011, 25(8), 1548-1556.
79. Lai, J. C.; Ananthakrishnan, G.; Jandhyam, S.; Dukhande, V. V.; Bhushan, A.; Gokhale, M.; Daniels, C. K.; Leung, S. W. Treatment of human astrocytoma U87 cells with silicon dioxide nanoparticles lowers their survival and alters their expression of mitochondrial and cell signaling proteins. Int. J. Nanomedicine, 2010, 5, 715-723.
80. Lee, T. L.; Raitano, J. M.; Rennert, O. M.; Chan, S. W.; Chan, W. Y. Accessing the genomic effects of naked nanoceria in murine neuronal cells. Nanomedicine, 2012, 8(5), 599-608.
81. Ciofani, G.; Genchi, G. G.; Liakos, I.; Cappello, V.; Gemmi, M.; Athanassiou, A.; Mazzolai, B.; Mattoli, V. Effects of cerium oxide nanoparticles on PC12 neuronal-like cells: proliferation, differentiation, and dopamine secretion. Pharm. Res., 2013, 30(8), 2133-2145.
82. Afeseh Ngwa, H.; Kanthasamy, A.; Gu, Y.; Fang, N.; Anantharam, V.; Kanthasamy, A. G. Manganese nanoparticle activates mitochondrial dependent apoptotic signaling and autophagy in dopaminergic neuronal cells. Toxicol. Appl. Pharmacol., 2011, 256(3), 227-240.
83. Prabhu, B. M.; Ali, S. F.; Murdock, R. C.; Hussain, S. M.; Srivatsan, M. Copper nanoparticles exert size and concentration dependent toxicity on somatosensory neurons of rat. Nanotoxicology, 2010, 4(2), 150-160.
84. Xue, Y.; Wu, J.; Sun, J. Four types of inorganic nanoparticles stimulate the inflammatory reaction in brain microglia and damage neurons in vitro. Toxicol. Lett., 2012, 214(2), 91-98.
85. Wu, D.; Pak, E. S.; Wingard, C. J.; Murashov, A. K. Multi-walled carbon nanotubes inhibit regenerative axon growth of dorsal root ganglia neurons of mice. Neurosci. Lett., 2012, 507(1), 72-77.
86. Zha, Y. Y.; Yang, B.; Tang, M. L.; Guo, Q. C.; Chen, J. T.; Wen, L. P.; Wang, M. Concentration-dependent effects of fullerenol on cultured hippocampal neuron viability. Int. J. Nanomedicine, 2012, 7, 3099-3109.
87. Prasad, B. R.; Mullins, G.; Nikolskaya, N.; Connolly, D.; Smith, T. J.; Gerard, V. A.; Byrne, S. J.; Davies, G. L.; Gun'ko, Y. K.; Rochev, Y. Effects of long-term exposure of gelatinated and nongelatinated cadmium telluride quantum dots on differentiated PC12 cells. J. Nanobiotechnology, 2012, 10, 4.
88. Shan, D.; Xie, Y.; Ren, G.; Yang, Z. Inhibitory effect of tungsten carbide nanoparticles on voltage-gated potassium currents of hippocampal CA1 neurons. Toxicol. Lett., 2012, 209(2), 129-135.
89. Shan, D.; Xie, Y.; Ren, G.; Yang, Z. Attenuated effect of tungsten carbide nanoparticles on voltage-gated sodium current of hippocampal CA1 pyramidal neurons. Toxicol. in Vitro, 2013, 27(1), 299-304.
90. Gramowski, A.; Flossdorf, J.; Bhattacharya, K.; Jonas, L.; Lantow, M.; Rahman, Q.; Schiffmann, D.; Weiss, D. G.; Dopp, E. Nanoparticles induce changes of the electrical activity of neuronal networks on microelectrode array neurochips. Environ. Health Perspect., 2010, 118(10), 1363-1369.
91. NIOSH Occupational Exposure to titanium dioxide. NIOSH Intelligence Bulletin NIOSH: 2011; pp 1-119.
92. NIOSH Occupational Exposure to Carbon Nanotubes and Nanofibers. NIOSH Intelligence Bulletin (Nov. 2010 Draft Version); 2010.